Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 6/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.35 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.35 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.35 |
| ▸ | APP | P05067 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29400181 | 1.00 | SIGMAR1 (0.41) | SIGMAR1CA12CA1CA2CA9 | |
| SCHEMBL14309781 | 1.00 | SIGMAR1 (0.41) | SIGMAR1CA12CA1CA2CA9 | |
| SCHEMBL10135860 | 1.00 | SIGMAR1 (0.41) | SIGMAR1CA12CA1CA2CA9 | |
| SCHEMBL18639048 | 1.00 | SIGMAR1 (0.41) | SIGMAR1CA12CA1CA2CA9 | |
| SCHEMBL13854535 | 1.00 | SIGMAR1 (0.41) | SIGMAR1CA12CA1CA2CA9 | |
| SCHEMBL20415604 | 1.00 | SIGMAR1 (0.41) | SIGMAR1CA12CA1CA2CA9 | |
| SCHEMBL17780058 | 1.00 | SIGMAR1 (0.41) | SIGMAR1CA12CA1CA2CA9 | |
| SCHEMBL17780184 | 1.00 | SIGMAR1 (0.41) | SIGMAR1CA12CA1CA2CA9 | |
| SCHEMBL21710743 | 1.00 | SIGMAR1 (0.41) | SIGMAR1CA12CA1CA2CA9 | |
| SCHEMBL13854528 | 1.00 | SIGMAR1 (0.41) | SIGMAR1CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3010068-B1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2020-12-09 | — | — | EP | disclosed |
| US-20160111665-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-04-21 | — | — | US | disclosed |
| US-20160111665-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-04-21 | — | — | US | disclosed |
| EP-3010068-A1 | ORGANIC LIGHT-EMITTING DEVICE | Samsung Display Co., Ltd. (KR) | 2016-04-20 | — | — | EP | disclosed |
| US-8883324-B2 | Aromatic amine derivative and organic electroluminescent device using same | IDEMITSU KOSAN CO., LTD. (JP) | 2014-11-11 | — | — | US | disclosed |
| US-8883324-B2 | Aromatic amine derivative and organic electroluminescent device using same | IDEMITSU KOSAN CO., LTD. (JP) | 2014-11-11 | — | — | US | disclosed |
| US-20120302793-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | IDEMITSU KOSAN CO., LTD. | 2012-11-29 | — | — | US | disclosed |
| US-20120302793-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | IDEMITSU KOSAN CO., LTD. | 2012-11-29 | — | — | US | disclosed |
| US-20120228594-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-09-13 | — | — | US | disclosed |
| US-20120228594-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-09-13 | — | — | US | disclosed |
| US-20120184776-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-07-19 | — | — | US | disclosed |
| US-20120184776-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-07-19 | — | — | US | disclosed |
| US-20120112176-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-05-10 | — | — | US | disclosed |
| US-20120112176-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-05-10 | — | — | US | disclosed |
| US-20080303417-A1 | Aromatic Amine Derivative and Organic Electroluminescent Device Using Same | IDEMITSU KOSAN CO., LTD. (JP) | 2008-12-11 | — | — | US | disclosed |
| US-20080303417-A1 | Aromatic Amine Derivative and Organic Electroluminescent Device Using Same | IDEMITSU KOSAN CO., LTD. (JP) | 2008-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120184776-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | EML4, DDC, ALKBH2 | SIGMAR1 2116/4885CA12 3655/4885CA1 2980/4885 |
| US-20120302793-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | NAT1, AFF1, AOC2 | SIGMAR1 468/4885CA12 4489/4885CA1 4308/4885 |
| US-20120112176-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | EML4, DDC, ALKBH2 | SIGMAR1 2138/4885CA12 3739/4885CA1 3019/4885 |
| US-20080303417-A1 | Aromatic Amine Derivative and Organic Electroluminescent Device Using Same | DDC, AOC2, ALKBH2 | SIGMAR1 1483/4885CA12 4036/4885CA1 3655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.